Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Overview
  • Distribution
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Frost & Sullivan Recognises Alere's Wide Palette of HIV Diagnostics Products with Cutting-edge Technologies
  • USA - English


News provided by

Frost & Sullivan

20 Aug, 2015, 12:30 IST

Share this article

Share toX

Share this article

Share toX

-- The company's product range covers all segments of HIV screening, staging, and monitoring

CAPE TOWN, South Africa, Aug. 20, 2015 /PRNewswire/ -- Based on its recent analysis of the HIV diagnostics market, Frost & Sullivan recognises Alere with the 2015 African Frost & Sullivan Award for Product Line Strategy Leadership. Alere has marched steadily to the top of the HIV diagnostic space with its array of testing products that deliver accurate results and leverage cost-effective technologies. It has one of the largest ranges of HIV diagnostic products in the African region.

Logo - http://photos.prnewswire.com/prnh/20150723/240707LOGO

The company has pioneered technologies for point-of-care testing products, enabling highly efficient workflows and quality test results. For instance, the Alere [TM] Pima Analyzer is the world's first device to provide absolute CD4 results at the point-of-care and helps providers initiate and improve the management of antiretroviral therapy. Some of its other solutions include Alere Determine™ HIV-1/2, Alere™ HIV Combo, Alere SD HIV/Syphilis Duo and Alere™ q HIV-1/2 Detect.

Alere's products are relatively easy to use and do not require extensive skill and clinical training, especially the Alere Determine HIV-1/2, Alere™ CD4 Analyzer, and the Alere q. While the Determine HIV-1/2 is dimensionally compact and generates results in 15 minutes, Alere's latest innovation, the Alere q is a first-of-its-kind, fully automated portable nucleic acid testing (NAT), which is the next generation point-of-care molecular platform. Additionally, Alere's molecular products have the capability to detect the widest range of subtypes and recombinant circulating forms (CRF) of HIV.

Already, more than 6,000 Alere Pima™ CD4 Analyzers have been deployed across Africa in various healthcare sites. In 2015 approximately 50 percent of these CD4 Analyzers will be connected wirelessly to health information systems (HIS) to offer better control, technical support and service, supply chain and logistics, and population-level data.

"Alere has a nimble manufacturing process, which gives it a distinct competitive advantage," said Frost & Sullivan Research Analyst Saravanan Thangaraj. "It has the ability and technology required to scale up the production and deliver large quantities of products without compromising quality. It also provides redundancy by having a number of manufacturing sites to ensure supply, in times of increased demand."

Alere presents a large portfolio of HIV diagnosis kits to international organisations including:

  • World Health Organization (WHO)
  • United States President's Emergency Plan for AIDS Relief (PEPFAR)
  • Doctors without Borders
  • The Global Fund
  • Clinton Health Access Initiative (CHAI), and
  • United Nations Children's Fund (UNICEF)

"In terms of affordability, Alere's HIV screening products are the assays of choice in more than 30 African nations," noted Thangaraj. "The solutions are designed to improve early diagnosis and turnaround time, reduce loss-to-follow-up, and enhance treatment compliance and adherence. This results in the best health economic outcomes to countries that employ the technology."

Africa needs a combination of a wide range of products and implementation support programs to manage the HIV pandemic. Alere has addressed this need by developing products that are tailored for the African market as well as by investing in the Field Support Staff (FSS) program, a regional support structure designed to maximise outcomes from point-of-care testing by offering training, mentorship and support.

Krishna Srinivasan, Global President and Managing Partner Frost & Sullivan stated, "Alere has done a remarkably good job of understanding customer needs in the HIV diagnostics market. Its diverse product range is uniquely positioned for sustained success because it addresses the core issues that customers care about – quality, functionality and reliability."

Owing to these differentiated technologies and customer-focused services, Alere is a worthy recipient of Frost & Sullivan's 2015 Product Line Strategy Leadership award.

Each year, Frost & Sullivan presents this award to the company that has developed a comprehensive product line that caters to the breadth of the market it serves. The award recognises the extent to which the product line meets customer base demands, the overall impact it has in terms of customer value as well as increased market share.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion

Join Us: Join our community

Subscribe: Newsletter on "the next big thing"

Register: Gain access to visionary innovation

Contact:

Samantha James
Corporate Communications – Africa
P: +27 21 680 3574
F: +27 21 680 3296
E: [email protected]
T: @FrostSullivanSA

Related Links

http://www.frost.com

Modal title

Also from this source

Index Exchange Receives Frost & Sullivan's 2025 Global New Product Innovation Recognition for Leadership in Supply-Side Platforms

Frost & Sullivan is pleased to announce that Index Exchange Inc (Index), one of the world's largest independent supply-side platforms (SSPs), has...

BioCatch Receives Frost & Sullivan's 2025 Global Competitive Strategy Leadership Recognition for Excellence in Fraud Detection and Prevention

Frost & Sullivan is pleased to announce that BioCatch, which prevents financial crime by recognizing patterns in human behavior, has earned the 2025...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.